ESC 2018: Cohort study of serious adverse events with SGLT2 inhibitors - Peter Jakobsson Ueda

 

Dr Peter Jakobsson Ueda discusses the cohort study of serious adverse events with SGLT2 inhibitors, filmed by Radcliffe Cardiology on site in Munich, ESC 2018.

Video Category: 

  • Diabetes